SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis
About this item
Full title
Author / Creator
Smeester, Branden A. , Slipek, Nicholas J. , Pomeroy, Emily J. , Bomberger, Heather E. , Shamsan, Ghaidan A. , Peterson, Joseph J. , Crosby, Margaret R. , Draper, Garrett M. , Becklin, Kelsie L. , Rahrmann, Eric P. , McCarthy, James B. , Odde, David J. , Wood, David K. , Largaespada, David A. and Moriarity, Branden S.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Semaphorins, specifically type IV, are important regulators of axonal guidance and have been increasingly implicated in poor prognoses in a number of different solid cancers. In conjunction with their cognate PLXNB family receptors, type IV members have been increasingly shown to mediate oncogenic functions necessary for tumor development and malig...
Alternative Titles
Full title
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2348284517
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2348284517
Other Identifiers
ISSN
0950-9232
E-ISSN
1476-5594
DOI
10.1038/s41388-019-1041-x
